These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33811783)

  • 1. Plasma neurofilament light chain levels predict improvement in late phase after stroke.
    Stokowska A; Bunketorp Käll L; Blomstrand C; Simrén J; Nilsson M; Zetterberg H; Blennow K; Pekny M; Pekna M
    Eur J Neurol; 2021 Jul; 28(7):2218-2228. PubMed ID: 33811783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofilament Light Chain (NfL) in Blood-A Biomarker Predicting Unfavourable Outcome in the Acute Phase and Improvement in the Late Phase after Stroke.
    Pekny M; Wilhelmsson U; Stokowska A; Tatlisumak T; Jood K; Pekna M
    Cells; 2021 Jun; 10(6):. PubMed ID: 34207058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of Serum Neurofilament Light Chain Levels and MRI Markers to Predict Cognitive Function in Ischemic Stroke.
    Peng Y; Li Q; Qin L; He Y; Luo X; Lan Y; Chen X; Wang X; Wang QM
    Neurorehabil Neural Repair; 2021 Mar; 35(3):247-255. PubMed ID: 33522401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer's disease pathology and clinical disease progression.
    Clark C; Lewczuk P; Kornhuber J; Richiardi J; Maréchal B; Karikari TK; Blennow K; Zetterberg H; Popp J
    Alzheimers Res Ther; 2021 Mar; 13(1):65. PubMed ID: 33766131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of plasma Neurofilament light as a diagnostic and prognostic biomarker of the postural instability gait disorder motor subtype in early Parkinson's disease.
    Ng ASL; Tan YJ; Yong ACW; Saffari SE; Lu Z; Ng EY; Ng SYE; Chia NSY; Choi X; Heng D; Neo S; Xu Z; Keong NCH; Tay KY; Au WL; Tan LCS; Tan EK
    Mol Neurodegener; 2020 Jun; 15(1):33. PubMed ID: 32503574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
    Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
    JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum neurofilament light: A biomarker of neuroaxonal injury after ischemic stroke.
    Tiedt S; Duering M; Barro C; Kaya AG; Boeck J; Bode FJ; Klein M; Dorn F; Gesierich B; Kellert L; Ertl-Wagner B; Goertler MW; Petzold GC; Kuhle J; Wollenweber FA; Peters N; Dichgans M
    Neurology; 2018 Oct; 91(14):e1338-e1347. PubMed ID: 30217937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma neurofilament light chain and glial fibrillary acidic protein predict stroke in CADASIL.
    Chen CH; Cheng YW; Chen YF; Tang SC; Jeng JS
    J Neuroinflammation; 2020 Apr; 17(1):124. PubMed ID: 32321529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NfL (Neurofilament Light Chain) Levels as a Predictive Marker for Long-Term Outcome After Ischemic Stroke.
    Uphaus T; Bittner S; Gröschel S; Steffen F; Muthuraman M; Wasser K; Weber-Krüger M; Zipp F; Wachter R; Gröschel K
    Stroke; 2019 Nov; 50(11):3077-3084. PubMed ID: 31537188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma neurofilament light chain in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional and longitudinal cohort study.
    Quiroz YT; Zetterberg H; Reiman EM; Chen Y; Su Y; Fox-Fuller JT; Garcia G; Villegas A; Sepulveda-Falla D; Villada M; Arboleda-Velasquez JF; Guzmán-Vélez E; Vila-Castelar C; Gordon BA; Schultz SA; Protas HD; Ghisays V; Giraldo M; Tirado V; Baena A; Munoz C; Rios-Romenets S; Tariot PN; Blennow K; Lopera F
    Lancet Neurol; 2020 Jun; 19(6):513-521. PubMed ID: 32470423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship Between Plasma Neurofilament Light Chain, Gut Microbiota, and Dementia: A Cross-Sectional Study.
    Saji N; Murotani K; Sato N; Tsuduki T; Hisada T; Shinohara M; Sugimoto T; Niida S; Toba K; Sakurai T
    J Alzheimers Dis; 2022; 86(3):1323-1335. PubMed ID: 35180112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study.
    de Wolf F; Ghanbari M; Licher S; McRae-McKee K; Gras L; Weverling GJ; Wermeling P; Sedaghat S; Ikram MK; Waziry R; Koudstaal W; Klap J; Kostense S; Hofman A; Anderson R; Goudsmit J; Ikram MA
    Brain; 2020 Apr; 143(4):1220-1232. PubMed ID: 32206776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dimethyl fumarate decreases neurofilament light chain in CSF and blood of treatment naïve relapsing MS patients.
    Sejbaek T; Nielsen HH; Penner N; Plavina T; Mendoza JP; Martin NA; Elkjaer ML; Ravnborg MH; Illes Z
    J Neurol Neurosurg Psychiatry; 2019 Dec; 90(12):1324-1330. PubMed ID: 31611264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseases.
    Thompson AGB; Anastasiadis P; Druyeh R; Whitworth I; Nayak A; Nihat A; Mok TH; Rudge P; Wadsworth JDF; Rohrer J; Schott JM; Heslegrave A; Zetterberg H; Collinge J; Jackson GS; Mead S
    Mol Psychiatry; 2021 Oct; 26(10):5955-5966. PubMed ID: 33674752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofilament light chain plasma concentration predicts neurodegeneration and clinical progression in nondemented elderly adults.
    Hu H; Chen KL; Ou YN; Cao XP; Chen SD; Cui M; Dong Q; Tan L; Yu JT;
    Aging (Albany NY); 2019 Sep; 11(17):6904-6914. PubMed ID: 31514172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurofilament light: a possible prognostic biomarker for treatment of vascular contributions to cognitive impairment and dementia.
    Hoyer-Kimura C; Konhilas JP; Mansour HM; Polt R; Doyle KP; Billheimer D; Hay M
    J Neuroinflammation; 2021 Oct; 18(1):236. PubMed ID: 34654436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum neurofilament light levels are predictive of all-cause mortality in late middle-aged individuals.
    Nguyen AD; Malmstrom TK; Aggarwal G; Miller DK; Vellas B; Morley JE
    EBioMedicine; 2022 Aug; 82():104146. PubMed ID: 35830835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma neurofilament light predicts mortality in patients with stroke.
    Gendron TF; Badi MK; Heckman MG; Jansen-West KR; Vilanilam GK; Johnson PW; Burch AR; Walton RL; Ross OA; Brott TG; Miller TM; Berry JD; Nicholson KA; Wszolek ZK; Oskarsson BE; Sheth KN; Sansing LH; Falcone GJ; Cucchiara BL; Meschia JF; Petrucelli L
    Sci Transl Med; 2020 Nov; 12(569):. PubMed ID: 33177179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Concentrations of Neurofilament Light Chain Protein and Brain-Derived Neurotrophic Factor as Consistent Biomarkers of Cognitive Impairment in Alcohol Use Disorder.
    Requena-Ocaña N; Araos P; Serrano-Castro PJ; Flores-López M; García-Marchena N; Oliver-Martos B; Ruiz JJ; Gavito A; Pavón FJ; Serrano A; Mayoral F; Suarez J; Fonseca FR
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum neurofilament light chain, brain infarcts, and the risk of stroke: a prospective population-based cohort study.
    Dhana A; DeCarli C; Aggarwal NT; Dhana K; Desai P; Evans DA; Rajan KB
    Eur J Epidemiol; 2023 Apr; 38(4):427-434. PubMed ID: 36867286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.